We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01018459
Recruitment Status : Completed
First Posted : November 23, 2009
Last Update Posted : June 6, 2014
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)